These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025

The Dow Jones Industrial Average got off to a solid start this year. The widely reported index, consisting of 30 large-cap stocks representing multiple sectors of the economy, gained 4.7% in the first month of the year.

While not all Dow index stocks did well in January, these five Dow stocks, which come from divergent sectors, vastly outperformed the index.

Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »

1. 3M

Industrial company 3M (NYSE: MMM) was the index's top performer in January with a 17.9% gain. Part of the stock's movement came after the company reported fourth-quarter results. Adjusted sales, which remove acquisitions/sales and foreign currency effects, grew 2.1% compared to a year ago. Diluted earnings per share fell 1.2% to $1.68.

2. International Business Machines

International Business Machines' (NYSE: IBM) shares soared 16.3%. Its fourth-quarter sales increased a tepid 2% after removing the effects of foreign currency translations. However, investors were undoubtedly pleased about IBM's progress on the generative artificial intelligence front with management reporting its book of business grew to $5 billion.

3. Goldman Sachs

Goldman Sachs' (NYSE: GS) stock price leaped 11.8% last month. The financial services company reported strong fourth-quarter results. Quarterly revenue grew 23% year over year to $13.9 billion, and diluted earnings per share more than doubled to $11.95.

Its businesses span investment banking, trading, asset management, and other banking services such as credit cards.

4. JPMorgan Chase

JPMorgan Chase (NYSE: JPM) saw its share price increase 11.5% in January. The banking giant reported fourth-quarter revenue grew 10.9%, driving diluted earnings per share more than 58% higher.

JPMorgan Chase's businesses include banking for consumers and businesses, investment banking, and asset management.

5. Amgen

Amgen's (NASDAQ: AMGN) shareholders were undoubtedly pleased with the stock's 9.5% appreciation. Although no specific news seemed to drive the price increase, the company has a history of developing treatments for ailments such as heart disease, cancer, and osteoporosis.

Given people need their medications, Amgen's results tend to do well no matter what happens with the economy and people's personal finances.

Should you invest $1,000 in 3M right now?

Before you buy stock in 3M, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and 3M wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $714,954!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

Learn more »

*Stock Advisor returns as of February 3, 2025

JPMorgan Chase is an advertising partner of Motley Fool Money. Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends 3M, Goldman Sachs Group, International Business Machines, and JPMorgan Chase. The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy.